Zika spread secrets tracked through new gene sequencing study

May 24, 2017

An international research collaboration studying the genetics of Zika virus in Brazil and beyond has provided a new understanding of the disease and its rapid spread through space and time. The research has significant public health implications and has the potential to improve responses to future outbreaks.

The research published today in Nature, was led by the Universities of Birmingham and Oxford in partnership with FioCruz Bahia, the University of São Paulo, and supported by the Brazilian Ministry of Health.

By carrying out genome sequencing to understand the virus' genetic make-up, the team was able to track the spread of the virus across Brazil. The study showed that Zika's establishment within Brazil - and its spread from there to other regions - occurred before Zika transmission in the Americas was first discovered. By revealing this 'hidden' epidemic, the results will help scientists to better understand the link between the Zika epidemic and reports of birth defects and other diseases.

With little known at the time about the epidemiology and evolution of Zika virus, the researchers travelled 2,000 km across the northeast Brazil in June last year. The team travelled in a minibus equipped with cutting-edge mobile DNA sequencing capabilities and tested samples from more than 1,300 patients infected with the virus.

In February 2016 Zika was declared a 'Public Health Emergency of International Concern' by the World Health Organisation (WHO) in response to evidence that the infection can cause birth defects in the foetuses of infected pregnant women. The virus can be transmitted from an infected pregnant woman to her developing baby, causing problems including severe microcephaly - a condition that results in babies being born with a smaller head size.

Dr. Nuno Faria, of the University of Oxford's Department of Zoology, said: "Despite there being probably millions of cases of the Zika virus in Brazil, there was only a handful of known virus genomes prior to our work. A better understanding of Zika virus' genetic diversity is critical to vaccine design, and also to identify areas where surveillance is most needed".

Professor Oliver Pybus, also of the University of Oxford's Department of Zoology said "We generated Zika virus genomes to establish the virus' epidemic history in the Americas. We showed that the virus was present in Brazil for a full year prior to the first confirmed cases in May 2015.

"We also found that northeast Brazil, which was the region with the most recorded cases of Zika and microcephaly, was the nexus of the epidemic in Brazil and played a key role in its spread within Brazil to major urban centres, such as Rio de Janeiro and São Paulo, before spreading across the Americas. We now have a better understanding of the epidemiology of the virus."

During the genome sequencing journey that travelled across Brazil, the researchers used the portable MinION DNA sequencer from the company Oxford Nanopore Technologies, which started as an Oxford University spinout company. The portable device weighs less than 100g and is powered by the USB port of a laptop, so is ideal for cross-country fieldwork.

Prof Nick Loman, of the University of Birmingham's School of Biosciences, said: "Genome sequencing has become a powerful tool for studying emerging infectious diseases, however, genome sequencing directly from clinical samples without isolation remains challenging for viruses such as Zika.

"We developed a new protocol that allows for real-time genomic sequencing - something of vital importance when managing viral outbreaks as it can provide real insight into how a virus is spreading, transmitting and evolving.

"What's more, using equipment like portable nanopore sequencing we were able to carry out emergency epidemiological research more quickly, to get immediate results when working in the field, as on the road in Brazil.

"This new protocol will doubtless prove hugely beneficial to researchers working in remote areas around the world during times of viral outbreaks."

The research project was funded by the Medical Research Council's Zika Rapid Response Initiative, USAID, and supported by the Wellcome Trust and the Newton Fund. It highlights the importance of creating trusted cross-institutional partnerships and sharing data openly during disease focused research fieldwork.

What is next? Prof Luiz Alcantara from FioCruz Bahia, Brazil hints that: "The project is now expanding to other geographic areas in Brazil, where we are tackling not only Zika virus but also dengue and chikungunya viruses, as well as the very recent ongoing yellow fever epidemics. The threat posed from viruses transmitted by mosquitos in Brazil is severe and there is a pressing need to better understand their epidemiology in order to prevent their spread."

As part of a co-operative international effort to share valuable data and results, the report was published together with two companion papers on the genetics and evolution of the Zika virus epidemic (for more details see DOI: 10.1038/nature22400 and DOI: 10.1038/nature22402). Zika remains a significant public health threat and the research highlights a need for continued research and surveillance of Zika and other mosquito-transmitted viruses in Brazil. Together, the papers paint a collective picture of the scale of impact of Zika, offering potential recommendations for future rapid detection and control of virus epidemics.
-end-
For further information or interviews contact:

1. Emma McKinney, Press Office, University of Birmingham, at 0121 414 6681 or e.j.mckinney@bham.ac.uk

2. Lanisha Butterfield, Media Relations Manager, University of Oxford, at 01865 280531 or lanisha.butterfield@admin.ox.ac.uk

Images: images shot by Ricardo Funari on the first Zibra trip: http://brazilphotos.photoshelter.com/gallery/Zibra/G0000BdsKkRd8noc/C0000BUkYX6obpqE

Password zibra
Image credit: Ricardo Funari

MinION genome sequencer : https://nanoporetech.com/about-us/for-the-media

Notes to Editors



University of Oxford

Related Genome Sequencing Articles from Brightsurf:

Tracking the SARS-CoV-2 virus with genome sequencing
Dirk Dittmer, PhD, professor of microbiology and immunology at the UNC School of Medicine, is tracking the virus that causes COVID-19 by sequencing the genome of virus samples collected from diagnostic testing.

Genome sequencing accelerates cancer detection
Recent cancer studies have shown that genomic mutations leading to cancer can occur years, or even decades, before a patient is diagnosed.

Whole genome sequencing reveals genetic structural secrets of schizophrenia
UNC School of Medicine scientists have conducted the largest-ever whole genome sequencing study of schizophrenia to provide a more complete picture of the role the human genome plays in this disease.

Using whole-genome sequencing for early identification and containment of AMR pathogens
A study published today examines the evolutionary and epidemiologic history of an epidemic strain of extensively drug-resistant tuberculosis (XDR-TB) -- called LAM4/KZN.

Whole genome sequencing could help save pumas from inbreeding
The first complete genetic sequences of individual mountain lions point the way to better conservation strategies for saving threatened populations of the wild animals.

Researchers move beyond sequencing and create a 3D genome
St. Jude Children's Research Hospital scientists have taken whole genome sequencing to the next level by creating a 3D map of the genome to better understand development and disease.

Clinical utility of rapid whole genome sequencing in neonates with seizures
Clinical utility of rWGS in the evaluation of neonatal seizures.

Viral genome sequencing in the heart of a Lassa outbreak
The first researchers to deploy a mobile nanopore sequencing technology to evaluate viral genomics at the height of a Lassa virus outbreak in 2018 now report their results.

New era for blood transfusions through genome sequencing
In a new study, investigators from Brigham and Women's Hospital and Harvard Medical School, as well as from the New York Blood Center have leveraged the MedSeq Project -- the first randomized trial of whole genome sequencing in healthy adults -- to develop and validate a computer program that can comprehensively and cost-effectively determine differences in individuals' blood types with more than 99 percent accuracy.

Does genome sequencing increase downstream costs?
The MedSeq Project, led by investigators at Brigham Women's Hospital, is the first randomized trial to provide whole genome sequencing to both presumably healthy patients as well as those with a known cardiology issue.

Read More: Genome Sequencing News and Genome Sequencing Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.